Restructuring actions, including cash and non-cash impacts, follow: | | | | | | | | | | | | | | | | | | | | | (Millions) | | Employee-Related | | Asset-Related and Other | | Total | Expense incurred in the fourth quarter of 2020 | | $ | 101 | | | $ | 36 | | | $ | 137 | | Non-cash changes | | — | | | (36) | | | (36) | | Accrued restructuring action balances as of December 31, 2020 | | 101 | | | — | | | 101 | | Incremental expense incurred in 2021 | | 124 | | | — | | | 124 | | Cash payments | | (127) | | | — | | | (127) | | Adjustments | | (11) | | | — | | | (11) | | Accrued restructuring action balance as of December 31, 2021 | | 87 | | | — | | | 87 | | Incremental expense incurred in the first quarter of 2022 | | 18 | | | — | | | 18 | | Cash payments | | (84) | | | — | | | (84) | | Adjustments | | (9) | | | — | | | (9) | | Accrued restructuring action balances as of June 30, 2022 | | $ | 12 | | | $ | — | | | $ | 12 | |
Divestiture-related restructuring actions, including cash impacts, follow: | | | | | | | | | (Millions) | | Employee-Related | Expense incurred in the third quarter of 2022 | | 41 | | Cash payments | | (31) | | Accrued restructuring action balances as of December 31, 2022 | | $ | 10 | |
The divestiture-related restructuring actions were recorded in the income statement as follows: | | | | | | | | | (Millions) | | 2020 | Cost of sales | | $ | 42 | | Selling, general and administrative expenses | | 12 | | Research, development and related expenses | | 1 | | Total operating income impact | | $ | 55 | |
Divestiture-related restructuring actions, including cash and non-cash impacts, follow: | | | | | | | | | | | | | | | | | | | | | (Millions) | | Employee-Related | | Asset-Related and Other | | Total | Expense incurred in the second quarter of 2020 | | $ | 32 | | | $ | 23 | | | $ | 55 | | Non-cash changes | | — | | | (14) | | | (14) | | Cash payments | | (14) | | | — | | | (14) | | Adjustments | | (3) | | | — | | | (3) | | Accrued restructuring action balance as of December 31, 2020 | | 15 | | | 9 | | | 24 | | Cash Payments | | (5) | | | — | | | (5) | | Adjustments | | (1) | | | — | | | (1) | | Accrued restructuring action balance as of June 30, 2021 | | $ | 9 | | | $ | 9 | | | $ | 18 | |
The restructuring charges were recorded in the income statement as follows: | | | | | | | | | (Millions) | | 2020 | Cost of sales | | $ | 13 | | Selling, general and administrative expenses | | 37 | | Research, development and related expenses | | 8 | | Total operating income impact | | $ | 58 | |
The business segment operating income impact of these restructuring charges is summarized as follows: | | | | | | | | | | | | | | | | | | | | | | | 2020 | (Millions) | | Employee-Related | | Asset-Related and Other | | Total | Safety and Industrial | | $ | 7 | | | $ | — | | | $ | 7 | | Transportation and Electronics | | 11 | | | — | | | 11 | | Health Care | | 12 | | | — | | | 12 | | Consumer | | 5 | | | — | | | 5 | | Corporate and Unallocated | | — | | | 23 | | | 23 | | Total Operating Expense | | $ | 35 | | | $ | 23 | | | $ | 58 | |
Restructuring actions, including cash and non-cash impacts, follow: | | | | | | | | | | | | | | | | | | | | | (Millions) | | Employee-Related | | Asset-Related | | Total | Expense incurred in the second quarter of 2020 | | $ | 35 | | | $ | 23 | | | $ | 58 | | Non-cash changes | | — | | | (23) | | | (23) | | Cash payments | | (2) | | | — | | | (2) | | Adjustments | | (9) | | | — | | | (9) | | Accrued restructuring action balances as of December 31, 2020 | | 24 | | | — | | | 24 | | Cash Payments | | (4) | | | — | | | (4) | | Adjustments | | (9) | | | — | | | (9) | | Accrued restructuring action balances as of March 31, 2021 | | $ | 11 | | | $ | — | | | $ | 11 | |
|